CellWell record HH-618452
50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?
Jordan VC
Endocrine-related cancer ยท 2021
In plain language
This review traces ICI 46,474, first investigated for fertility control, to its later clinical use as a breast cancer drug, which a 1971 trial showed active versus alternatives.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-618452
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.